Prof Yosef Yarden, a recipient of the 2017 Israel Prize in Life Sciences, is Director of the Dwek Institute for Cancer Therapy Research of the Moross Integrated Cancer Center and a member of the Weizmann Institute’s Department of Biological Regulation.

Prof. Yarden’s discoveries have led to the development of several successful anti-cancer drugs. Much of his research is centred on EGFR and HER2, and several of his strategies for blocking these receptors have been devised and approved for use with cancer patients. Most recently, the Yarden lab has been investigating strategies for circumventing the resistance that some lung cancer patients develop to anti-cancer immunotherapy.

All Staff and Students welcome

A buffet lunch will be on offer after the seminar